Skip to content

Comparison of two drugs bupivacaine and ropivacaine given in spinal anesthesia in patients undergoing surgery vaginal hysterectomy.

A prospective study comparing hyperbaric Bupivacaine and hyperbaric Ropivacaine in patients undergoing elective vaginal hysterectomy under subarachnoid blockade.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053746
Enrollment
60
Registered
2023-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

Control Intervention1: Ropivacaine 0.75% heavy: 3ml of Bupivacaine 0.5% heavy is compared with 3ml Ropivacaine 0.75% heavy under subarachnoid blockade .Duration of surgery is 120 min. Control Interven

Sponsors

Dr RPGMC Kangra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 & 2 BMI (18-29.9) UNDERGOING ELECTIVE VAGINAL HYSTERECTOMY WITH AN ANTICIPATED DURATION OF 120 MINUTES

Exclusion criteria

Exclusion criteria: REFUSAL TO PARTICIPATE IN STUDY ALLERGY TO STUDY DRUG OBESITY (BMI >30) HEIGHT 180CM PATIENTS IN WHICH SPACE OTHER THAN L3-L4 WAS USED FOR SUBARACHNOID BLOCK PATIENTS WITH ABSOLUTE CONTRAINDICATIONS TO SPINAL ANAESTHESIA

Design outcomes

Primary

MeasureTime frame
To compare the block characteristics among two groups (sensory, motor and duration of analgesia To study hemodynamic parameters among two groups(PR, SBP, DBP, MAP)Timepoint: Time of injection of spinal drug(0 min) Time of onset of sensory block(T12) Time to achieve peak sensory block Peak sensory level Max sensory level after 20 min Two segment regression time Duration of sensory block Total duration of analgesia Onset of motor block (MBS 1) Time to achieve complete motor block (MBS 3) Max bromage score achieved Duration of motor block Hemodynamic variables at 5 min interval initially and then 15 min interval til the end of surgery

Secondary

MeasureTime frame
Any adverse events (hypotension, bradycardia, nausea and vomiting)Timepoint: Total duration of surgery Any side effect

Countries

India

Contacts

Public ContactIshita Katna

Dr Rajendra Prasad Govt Medical College

dr.bhandari@yahoo.co.in9805135129

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026